Document is current
Any future updates will be listed below
-
Authors
Kasahara, Yuki
Saijo, Ken
Ueta, Reio
Numakura, Ryunosuke
Sasaki, Keiju
Yoshida, Yuya
Taniguchi, Sakura
Ouchi, Kota
Komine, Keigo
Imai, Hiroo
Shirota, Hidekazu
Takahashi, Masanobu
Ishioka, Chikashi
-
Funding
Funding for this research was provided by:
Eisai
Adlai Nortye
MSD
Ono Pharmaceutical
Chugai Pharmaceutical
Merck Pharmaceutical
Boehringer Ingelheim
Taiho Pharmaceutical
Daiichi Sankyo Company
Asahi Kasei Pharma
Bayer Yakuhin
Nippon Kayaku
Takeda Pharmaceutical
- License Information
-
More Information
Article History
Received: 1 March 2024
Accepted: 6 November 2024
First Online: 16 November 2024
Declarations
:
: The authors declare no competing interests.
: This study was approved by the Ethics Committee of the Faculty of Medicine of the Tohoku University School of Medicine (Approval No.2021-1-351) and performed in line with the ethical standards described in the Declaration of Helsinki.
: Patient consent for this study was obtained with the opt-out method.
